ATXS icon

Astria Therapeutics
ATXS

Overview Fund Trends Analyst Outlook Journalist POV

33 hedge funds and large institutions have $32.8M invested in Astria Therapeutics in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less ownership

Funds ownership: →

29% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 7

49% less capital invested

Capital invested by funds: $63.8M → $32.8M (-$30.9M)

Holders
33
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.23M
Puts
$310K
Net Calls
Net Calls Change

Top Buyers

1
+$270K
2
+$243K
3
+$65K
4
BlackRock
BlackRock
New York
+$64.7K
5
Millennium Management
Millennium Management
New York
+$55K

Top Sellers

1
-$3.66M
2
-$2.12M
3
-$994K
4
Citadel Advisors
Citadel Advisors
Florida
-$475K
5
Renaissance Technologies
Renaissance Technologies
New York
-$404K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$16K
27
$12K
28
$11K
29
$2K
30
$1K
31
–
32
–
33
–
34
–
35
–
36
–
37
–
1
2